Metronidazole and glucose injection

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

This product is a compound preparation, its components are: metronidazole 0.2%, glucose 5%.

Mainly used to treat anaerobic infections

Intravenous drip. 1 Common dosage for adults: For anaerobic infection, the first dose is 15 mg/kg (1 g for a 70 kg adult) by intravenous drip, and the maintenance dose is 7.5 mg/kg by intravenous drip every 6 to 8 hours. 2 Common dosage for children: The injection dose for anaerobic infection is the same as that for adults.

Adverse reactions occur in 15% to 30% of cases, with gastrointestinal reactions being the most common, including nausea, vomiting, loss of appetite, and abdominal cramps, which generally do not affect treatment; neurological symptoms include headache, dizziness, occasional paresthesia, limb numbness, ataxia, multiple neuritis, etc., and large doses can cause convulsions. A small number of cases develop urticaria, hot flashes, itching, cystitis, dysuria, metallic taste in the mouth, and leukopenia, all of which are reversible and recover on their own after stopping the drug.

It is contraindicated for patients with active central nervous system diseases and blood diseases.

This product can enhance the effect of anticoagulant drugs such as warfarin.

Keep away from light and store in a sealed container.

250ml: Metronidazole 0.5g and glucose 12.5g

Shanxi Tianzhi Pharmaceutical Co., Ltd.

• Founded in:

  2003-01-24

• Address:

  No. 7, Nanbei Street, Xinfu District, Xinzhou City, Shanxi Province (one license, multiple addresses)

• Tax NO.:

  91140902111893526T

• Registered Funds:

  133 million yuan

• Website:

  Log in to view

• Email:

  Log in to view